Login / Signup

Letter: SPOSIB SB2-a Sicilian prospective observational study of IBD patients treated with infliximab biosimilar SB2.

Fabio Salvatore MacalusoMaria CappelloEnrica GiuffridaWalter FriesAndrea CentrittoAntonio Carlo PriviteraGaetano InserraRoberto VassalloAntonio MagnanoElisa VinciSerena GarufiMarco VentimigliaSara RennaRosalba OrlandoGiulia RizzutoMario CottoneAmbrogio Orlandonull null
Published in: Alimentary pharmacology & therapeutics (2019)
Keyphrases
  • ulcerative colitis